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ABSTRACT
DBTSS is a database of transcriptional start sites,
based on our unique collection of precise, experi-
mentally determined 5’-end sequences of full-length
cDNAs. Since its first release in 2002, several major
updates have been made. In this update, we
expanded the human transcriptional start site
dataset by 19 million uniquely mapped, and
RefSeq-associated, 5’-end sequences, which were
generated by a newly introduced Solexa sequencer.
Moreover, in order to provide means for interpreting
those massive TSS data, we implemented two new
analytical tools: one for connecting expression
information with predicted transcription factor bind-
ing sites; the other for examining evolutionary
conservation or species-specificity of promoters
and transcripts, which can be browsed by our own
comparative genome viewer. With the expanded
dataset and the enhanced functionalities, DBTSS
provides a unique platform that enables in-depth
transcriptome analyses. DBTSS is accessible at
http://dbtss.hgc.jp/.
INTRODUCTION
One of the most challenging subjects of the genome
science in the post-genome-sequencing era is to under-
stand the transcriptional regulatory networks, by which
the timing and quantity of transcriptions are collectively
controlled. To eventually decode the genome information
into a macromolecular system of the cell, in-depth
knowledge of its higher-order regulatory mechanisms
should be indispensable (1,2). It is also expected that
detailed evolutionary comparisons of transcriptional net-
works would explain molecular mechanisms underlying
the phenotypic divergence and speciation (3). Therefore,
the identiﬁcation and analyses of promoters, where most
of the binding sites of transcription factors are contained,
are essential. To deﬁne promoter regions, positional
information about transcriptional start sites (TSSs) is the
ﬁrst clue (4).
In order to provide the precise information of TSSs, we
launched DBTSS in 2002 (5). DBTSS contains the TSS
information determined with our experiments. The 50-end
sequences of full-length cDNA clones isolated from
libraries, which are mainly constructed by the oligo-
capping method and are enriched in full-length cDNAs,
are mapped on to genome sequences. Each TSS is
determined as a genomic position to which the 50-end of
some full-length cDNAs is corresponded (6). Since the
initial release of DBTSS, we have made several updates,
including the expansion of the data amount as well as the
covered species, the addition of the information of
so-called alternative promoters (7), and the implementa-
tion of an analytical tool, which enables the promoter
sequence comparison between human and mouse. In this
article, we introduce new updates and additions since
DBTSS 2006, the most important one being the addition
of TSS information which has been massively produced by
a new-generation sequencer.
Newly developed, massively parallel sequencing tech-
nologies, such as GS20 and Solexa sequencer systems,
have enabled to determine millions of sequences in a single
run (8). We recently accommodated our full-length cDNA
technique, the oligo-capping method, for the Solexa
sequencers (detailed protocol will be published elsewhere).
Utilizing the extremely high-throughput Solexa sequencer,
we generated 19-million TSS information and incorpo-
rated it into DBTSS. At the same time, we also considered
that, in order to maximally extract biological information
from this size of TSS data, the implementation of powerful
analytical tools should be essential. Therefore, in
this update, together with the expansion of the TSS
data, we put two analytical tools into service; the ﬁrst
for correlating expression information with promoter
elements; the second for examining the evolutionary
conservation or species-speciﬁcity of promoters and
transcripts, which can be browsed by a dynamic and
ﬂexible comparative genome browser. Both of these
new functionalities are closely related with the Solexa
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of the TSS data.
NEW FEATURES
Incorporation of theTSS dataproduced
bythe Solexasequencer
A major update of the current version of DBTSS, version
6, since the previous report, is that the amount of data for
human TSSs has been signiﬁcantly increased. We recently
started to determine the 50-end sequences of the oligo-
capped cDNAs using the Solexa sequencer. Brieﬂy, 50- and
30-adaptor sequences necessary for the Solexa sequencing
were introduced as a 50-end-oligo at the RNA ligation and
as a random hexamer primer at the ﬁrst strand cDNA
synthesis, respectively. Because of this straightforward
procedure, thereby collected data should be improved
by its size without degrading its quality. Obtained data
were processed as previously described for the classical
Sanger sequences with some minor modiﬁcations. The
genomic positions to which the 50-ends of the Solexa
sequences were mapped were deﬁned as putative TSSs.
Clustering by 500bp bins was also applied to separate
putative alternative promoters (7). As a result, 10000349
and 8633345 sequences were obtained from the MCF7
cells (a human cell line of breast cancer origin;
ATCC#HTB-22) and the human embryonic kidney 293
cells (HEK293; ATCC#CRL-1573), respectively, which
were uniquely mapped to the RefSeq mRNA regions of
the human genome (hg18). Those sequences collectively
represent 29210 and 41238 putative (alternative) promo-
ters of 12133 and 11598 RefSeq genes in the two cell lines,
respectively (Table 1). This is one of the largest collections
of human TSS information collected from a single cell
type (9).
The Solexa data can be retrieved in parallel with the
original Sanger data (Figure 1). In other words, we did not
mix the new TSS information from the Solexa data with
the original dataset so that the in-depth transcriptome
analysis focusing on a single cell type is possible, while the
previous data representing general features of promoters
taken from the data of various cell types and tissues, could
be preserved. Otherwise, the clustering and the representa-
tions of the promoters in the original dataset could be
severely biased because of the size of the new data.
Connectingexpression information withpromoter elements
In order to further investigate the biological signiﬁcance
or the underlying regulatory mechanisms of the observed
TSSs, the information on the changes of expression levels
invoked by various environmental stimulations would
provide important clues. For this purpose, at least before
the expression information produced by the Solexa and
the GS20 sequencers [where millions of collected
sequences are subjected to the SAGE-like analysis; see
(10)] will be accumulated to some suﬃcient level, hitherto
compiled microarray data are conveniently available. In
particular, for MCF 7, there is a series of microarray data,
which was recently produced by the Connectivity Map
project, representing the expression proﬁles of this
particular cell on the administrations of over 200 kinds
of drugs in several time courses (11).
In addition to the incorporation of the MCF7 expres-
sion data, we implemented an analytical tool. This
analytical tool looks for putative transcription factor
binding sites commonly occurring in the promoters, which
show similar behaviors on various drug perturbations.
It is assumed that those promoters should be under the
regulations of similar transcription factors, thus, contain-
ing particular transcription factor binding sites in
common. As shown in Figure 2, as for the user-speciﬁed
group of promoters or promoters which satisfy some
speciﬁed search conditions on the expression proﬁles,
transcription factor binding sites are predicted by
the matrix search of the TRANFAC database (12)
under any cut-oﬀ values. The degree of enrichment of
the predicted transcription factor binding sites is evaluated
assuming the hypergeometric distributions. Thereby, the
enriched binding sites are listed and users can further
retrieve the information regarding in which promoters and
in which part of them these sites are located. Although
the MCF7 dataset is currently the only resource of the
expression data, we will further expand the dataset to
cover expression proﬁles in various cell types and
conditions. Moreover, further increases in the amount of
the Solexa data for TSS determination themselves will
enrich the source of expression information. Such data
will directly couple the positional information within
promoters with the changes of expression levels, as the
latter should be represented by the number of allocated
sequences.
Evolutionary conservation ofpromoters and their
downstream transcripts
Another approach to infer the biological relevance of the
TSSs is to examine the details of their evolutionary
conservation or turnovers in both their upstream promo-
ters and downstream transcribed regions. Recently, it has
become clear that some of the (alternative) promoters are
Table 1. Statistics of the datasets produced by the Solexa sequencer
(upper two rows) and by the original Sanger sequencer (bottom row) in
humans. TSSs which were supported by equal or greater than ﬁve
sequences were counted for the Solexa datasets
Total no.
of mapped
sequences
No. of
sequences
associated
with NMs
No.
represented
NMs
Total no.
of putative
promoters
MCF7
(Solexa)
11919330 10000349 12133 29210
HEK293
(Solexa)
10062560 8633345 11598 41238
CDNA
(Sanger, total)
1540411 1370985 15194 32122
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Whether the non-conserved (alternative) promoters
are the noise of transcription or actually playing
species-speciﬁc roles still remains elusive. However,
further ways for investigating those (alternative) promot-
ers should be diﬀerent from the ﬁrst step, depending on
whether they are associated with conserved, possibly
principal, biological roles or species-speciﬁc phenotypic
features.
As shown in Figure 3, our new comparative browser
enables users to examine evolutionary conservation of the
surrounding regions of TSSs, based on the genomic
sequences of various kinds of mammals, such as mice,
rats and monkeys, as well as their mutual base-pair
alignments from the UCSC Genome Browser (14).
Furthermore, users can search for the promoters or
transcripts according to the degree of evolutionary
conservation, using variable parameters, including the
coverage of alignable regions and the base substitution
rate therein. Further detailed searches focusing on limited
regions of the transcripts, such as UTRs, CDSs or the
‘coding exons’ are also supported. These results are
browsed with our new comparative browser, which
provides the dynamic magniﬁcation from the sequence
level to the overview level. This viewer currently supports
up to four-way comparisons between four genomes of
user’s choice.
FUTURE PERSPECTIVE
We will continue Solexa sequencing in various tissues with
various environmental conditions, by which not only TSS
Figure 1. Screenshot from the Solexa sequence viewer. Its basic utility is similar to that of the previous version (5). Users can choose the database to
search, either Sanger or Solexa dataset, in the left panel and then retrieve the results (red circle). Users can also switch the browsers between the
Sanger and Solexa results (blue circle).
Nucleic Acids Research, 2008, Vol. 36, Database issue D99data but also expression data will be increased further.
We will also take a similar approach for model organisms
other than humans. Their relevant data will be incorpo-
rated into DBTSS and made publicly available. Especially,
in many organisms, their cDNA resources still remain
scarce, while the genome sequences are being hastily
released. Our massive transcriptome data will be most
helpful not only for determining TSSs and upstream
promoters but also for putting accurate annotations for
the compiled genome sequences. DBTSS, with expanded
data and supported by several new analytical tools,
provides a unique platform for enabling in-depth analyses
of transcriptomes. We believe DBTSS will serve as a ﬁrm
foundation leading us into deeper insights on how the
transcriptional regulatory network is realized by the code
of genomic DNA sequences.
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Figure 2. Screenshot from the search engine for enrichment of the putative transcription factor binding sites (A). The ﬁgure exempliﬁes the search for
common TF binding sites appearing in the promoters of genes with which more than 10 Solexa sequences are associated and the relative expression
levels are more than 2-fold elevated both by the 1mm trichostatin A treatment and by the 1 mm wortmannin treatment (B). From the resultant list of
the enriched sites, the link can be followed to the main viewer to retrieve further detailed information (C).
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